Articles by Disease (Non Hodgkin's Lymphoma)

Emerging Concepts for the Treatment of Hematological Malignancies with Therapeutic Monoclonal Antibodies

Journal: Current Drug Targets
Volume: 11
Page: 790-800
Author(s): Aude-Helene Capietto, Samarh Keirallah, Emilie Gross, Nicolas Dauguet, Emilie Laprevotte, Christine Jean, Julie Gertner-Dardenne, Christine Bezombes, Anne Quillet-Mary, Mary Poupot, Loic Ysebaert, Guy Laurent and Jean-Jacques Fournie

Potential of Plant-Derived Natural Products in the Treatment of Leukemia and Lymphoma

Journal: Current Drug Targets
Volume: 11
Page: 812-822
Author(s): David M. Lucas, Patrick C. Still, Lynette Bueno Perez, Michael R. Grever and A. Douglas Kinghorn

LFA-1 on Leukemic Cells as a Target for Therapy or Drug Delivery

Journal: Current Pharmaceutical Design
Volume: 16
Page: 2321-2330
Author(s): Rungsinee Phongpradist, Chuda Chittasupho, Siriporn Okonogi, Teruna Siahaan, Songyot Anuchapreeda, Chadarat Ampasavate and Cory Berkland

Recognition of Nucleic Acids by Toll-Like Receptors and Development of Immunomodulatory Drugs

Journal: Current Medicinal Chemistry
Volume: 17
Page: 1899-1914
Author(s): A. Kuznik, G. Panter and R. Jerala

Targeting the p53-Family in Cancer and Chemosensitivity: Triple Threat

Journal: Current Drug Targets
Volume: 11
Page: 667-681
Author(s): J. Chung and M.S. Irwin

3-Nitro-Tyrosine as an Internal Quencher of Autofluorescence Enhances the Compatibility of Fluorescence Based Screening of OBOC Combinatorial Libraries

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 13
Page: 422-429
Author(s): Jared Townsend, Andrew Do, Alan Lehman, Seth Dixon, Babak Sanii and Kit S. Lam

Articles by Disease (Non Hodgkin's Lymphoma)

Emerging Concepts for the Treatment of Hematological Malignancies with Therapeutic Monoclonal Antibodies

Potential of Plant-Derived Natural Products in the Treatment of Leukemia and Lymphoma

LFA-1 on Leukemic Cells as a Target for Therapy or Drug Delivery

Recognition of Nucleic Acids by Toll-Like Receptors and Development of Immunomodulatory Drugs

Targeting the p53-Family in Cancer and Chemosensitivity: Triple Threat

3-Nitro-Tyrosine as an Internal Quencher of Autofluorescence Enhances the Compatibility of Fluorescence Based Screening of OBOC Combinatorial Libraries

Editorial [Hot topic: Recent Progress in Cancer Therapeutics (Guest Editor: Kurt S. Zaenker)]

An Augmented Passive Immune Therapy to Treat Fulminant Bacterial Infections

Activation of Sphingosine Kinase-1 in Cancer: Implications for Therapeutic Targeting

A Novel Technology for Hematopoietic Stem Cell Expansion Using Combination of Nanofiber and Growth Factors